Successful use of split dose intravenous daratumumab in an overweight multiple myeloma patient after first dose life threatening infusion-related reaction

Basit Öğe Kaydı
dc.authorid0000-0001-9636-4113
dc.contributor.authorAykaş, Fatma
dc.contributor.authorKarakuş, Volkan
dc.contributor.authorSevindik, Ömür Gökmen
dc.date.accessioned2023-03-09T07:24:40Z
dc.date.available2023-03-09T07:24:40Z
dc.date.issued2022
dc.departmentİstanbul Medipol Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, İç Hastalıkları Ana Bilim Dalı
dc.description.abstractIntroduction: There is a paucity of data regarding the best practice to institute iv Daratumumab (D) in morbid obese patients regarding the infusion rate and duration, optimal dosing, and ideal way to cope with the infusion related reactions (IRR). We wanted to present the fi rst split dose D infusion experience in a morbid obese MM case whose D was interrupted because of a grade 3 IRR.
dc.identifier.citationAykaş, F., Karakuş, V. ve Sevindik, Ö. G. (2022). Successful use of split dose intravenous daratumumab in an overweight multiple myeloma patient after first dose life threatening infusion-related reaction. Clinical Lymphoma, Myeloma & Leukemia içinde (S48-S49. ss.).
dc.identifier.endpageS49
dc.identifier.issn2152-2650
dc.identifier.issn2152-2669
dc.identifier.issueSupplement
dc.identifier.startpageS48
dc.identifier.urihttps://hdl.handle.net/20.500.12511/10588
dc.identifier.volume22
dc.identifier.wos000895909200081en_US
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.institutionauthorSevindik, Ömür Gökmen
dc.language.isoen
dc.publisherCIG Media Group
dc.relation.ispartofClinical Lymphoma, Myeloma & Leukemiaen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/embargoedAccess
dc.subjectIntravenous Daratumumab
dc.subjectInfusion-Related Reaction
dc.subjectMyeloma Patient
dc.titleSuccessful use of split dose intravenous daratumumab in an overweight multiple myeloma patient after first dose life threatening infusion-related reaction
dc.typeConference Object

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
Sevindik-Gokmen-2022.pdf
Boyut:
178.65 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
İndir
Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama:
İndir

Koleksiyon

Bildiri Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu